<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04887233</url>
  </required_header>
  <id_info>
    <org_study_id>214/64</org_study_id>
    <nct_id>NCT04887233</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Longan Extract Spray (P80 Spray) in Volunteers With Coronavirus Disease 2019 (COVID-19)</brief_title>
  <official_title>Efficacy and Safety of Longan Extract Spray (P80 Spray) in Volunteers With Coronavirus Disease 2019 (COVID-19)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this study are to evaluate efficacy and safety of longan extract spray (P80&#xD;
      spray) in volunteers with coronavirus disease 2019 (COVID19).Patients who infected COVID 19&#xD;
      (positive COVID 19 RT-PCR from nasal swab) are enrolled in the study. They will be treated&#xD;
      with standard treatment of COVID 19. In addition, the patients will received longan extract&#xD;
      nasal spray (P80 spray) or placebo nasal spray for 3 days (6 times). After that, they will be&#xD;
      nasal swabbed for detecting COVID 19 infection. Adverse event will also be evaluated by&#xD;
      physician or nurse.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients who infected COVID 19 (positive COVID 19 RT-PCR from nasal swab) and pass inclusion&#xD;
      criteria are enrolled in the study. The patients will be checked the clinical symptoms and&#xD;
      chest x-ray by physician. They will be treated with standard treatment of COVID 19. In&#xD;
      addition, the patients will received longan extract nasal spray (P80 spray) or placebo nasal&#xD;
      spray for 3 days (6 times). Physician or nurse will ask for adverse events every day. After 3&#xD;
      days, the patients will be nasal swabbed for detecting COVID 19 infection.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nasal swab test negative</measure>
    <time_frame>3 days</time_frame>
    <description>There will be a negative reverse transcriptase-polymerase chain reaction (RT-PCR) test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Absent of respiratory symptoms</measure>
    <time_frame>3 days</time_frame>
    <description>There will be a body temperature less than 37.5 degree celsius and absent of respiratory symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>No adverse event</measure>
    <time_frame>3 days</time_frame>
    <description>There will be no allergic reaction</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Infection Viral</condition>
  <arm_group>
    <arm_group_label>Longan nasal spray</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients will be received 2 puff of Longan nasal spray 2 times/day for 3 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo nasal spray</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The patients will be received 2 puff of placebo nasal spray 2 times/day for 3 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Longan nasal spray</intervention_name>
    <description>The patients will be received 2 puff of Longan nasal spray 2 times/day for 3 days.</description>
    <arm_group_label>Longan nasal spray</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>The patients will be received 2 puff of placebo nasal spray 2 times/day for 3 days.</description>
    <arm_group_label>Placebo nasal spray</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-60 years&#xD;
&#xD;
          -  Positive nasal swab test of coronavirus disease 2019 (COVID-19) (reverse&#xD;
             transcriptase-polymerase chain reaction (RT-PCR) เป็นบวก (cycle threshold &lt;40))&#xD;
&#xD;
          -  Mild symptom with normal chest radiograph&#xD;
&#xD;
          -  No history of Chronic Obstructive Pulmonary Disease (COPD) and other chronic lung&#xD;
             diseases, Chronic kidney disease (CKD), Cardiovascular diseases and congenital heart&#xD;
             diseases, Cerebrovascular diseases, Poorly controlled diabetes,BMI &gt; 35 kg/m2,&#xD;
             Cirrhosis, Immunocompromised condition&#xD;
&#xD;
          -  Can read and write&#xD;
&#xD;
          -  Vulnerable to participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergic history to longan&#xD;
&#xD;
          -  Uncontrollable disease status&#xD;
&#xD;
          -  Pregnancy or lactation&#xD;
&#xD;
          -  Participated in other studies&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pornanong Aramwit, Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>Chulalongkorn University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pornanong Aramwit, Ph.D</last_name>
    <phone>+66899217255</phone>
    <email>aramwit@gmail.com</email>
  </overall_contact>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 13, 2021</study_first_submitted>
  <study_first_submitted_qc>May 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2021</study_first_posted>
  <last_update_submitted>May 14, 2021</last_update_submitted>
  <last_update_submitted_qc>May 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulalongkorn University</investigator_affiliation>
    <investigator_full_name>Pornanong Aramwit, Pharm.D., Ph.D</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Longan</keyword>
  <keyword>nasal spray</keyword>
  <keyword>COVID 19</keyword>
  <keyword>efficacy</keyword>
  <keyword>safety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Virus Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

